Home / Health / India's HPV Vaccine: A Lifeline Against Cancer
India's HPV Vaccine: A Lifeline Against Cancer
19 Oct
Summary
- India faces a severe cervical cancer burden, with a quarter of global deaths.
- HPV vaccines are rigorously tested, safe, and effective, with global use.
- Preventing cervical cancer protects fertility, unlike its treatment.
Seven months after its launch, India's HPV vaccination program is showing promising results, with many girls coming forward for protection. This initiative is crucial as India accounts for a quarter of all cervical cancer deaths worldwide. Cervical cancer is largely preventable, driving efforts to make HPV vaccination a public health priority.
The HPV vaccine rollout follows strict scrutiny by Indian regulators, ensuring safety and efficacy. Globally, over 80 crore doses have been administered, with 160 countries including it in their programs. Studies confirm no link between HPV vaccination and fertility problems; conversely, cancer treatment can harm fertility.
The program ensures trained staff, medical supervision, parental consent, and national record-keeping via U-WIN. England saw no deaths among vaccinated young women, and Australia aims to eliminate the disease by 2035. India has a proven track record with vaccines, having eradicated polio.
Each girl turning 14 is eligible for a free dose, reaching approximately 1.15 crore girls annually. India's government has secured the vaccine and established a delivery system. Parental choice is now key to achieving a cervical cancer-free status.
